SCHEMBL23016136

SCHEMBL23016136

c1ccc2c(c1)cc(-c1ccc3cc(-c4ccc5nc(-c6cccc7ncccc67)ccc5c4)ccc3n1)c1ccccc12

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.48
POLB P06746 1/20 0.48
RAB9A P51151 1/20 0.48
CYP3A4 P08684 1/20 0.47
ERN1 O75460 2/20 0.46
ACVR1 Q04771 3/20 0.42
DYRK1A Q13627 1/20 0.41
LMNA P02545 1/20 0.39
CA12 O43570 1/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
CA9 Q16790 1/20 0.39
CYP11B1 P15538 1/20 0.39
FTO Q9C0B1 1/20 0.39
KDM5B Q9UGL1 1/20 0.39
KDM2A Q9Y2K7 1/20 0.39
FYN P06241 1/20 0.39
BPTF Q12830 1/20 0.38
ATR Q13535 1/20 0.38
MAP4K1 Q92918 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24475637 0.96 POLB (0.44) NPC1POLBRAB9ACYP3A4ERN1
SCHEMBL24475593 0.91 CYP3A4 (0.44) NPC1POLBRAB9ACYP3A4ERN1
SCHEMBL23016043 0.91 POLB (0.51) NPC1POLBRAB9ACYP3A4ERN1
SCHEMBL23016135 0.89 NPC1 (0.49) NPC1POLBRAB9ACYP3A4ERN1
SCHEMBL23016200 0.88 NPC1 (0.44) NPC1POLBRAB9ACYP3A4ERN1
SCHEMBL24475636 0.88 POLB (0.48) NPC1POLBRAB9ACYP3A4ERN1
SCHEMBL23016046 0.88 NPC1 (0.46) NPC1POLBRAB9ACYP3A4ERN1
SCHEMBL22281645 0.86 NPC1 (0.46) NPC1POLBRAB9ACYP3A4ERN1
SCHEMBL23016210 0.85 NPC1 (0.44) NPC1POLBRAB9ACYP3A4DYRK1A
SCHEMBL23016198 0.85 NPC1 (0.46) NPC1POLBRAB9ACYP3A4DYRK1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10930857-B2 Heterocyclic compound and organic light emitting device using same LT MATERIALS CO., LTD. (KR) 2021-02-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10930857-B2 Heterocyclic compound and organic light emitting device using same CRY1, CRY2, CYBA NPC1 4299/4885POLB 699/4885RAB9A 3913/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.